XML 70 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
Business Segments
 12 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Business Segments
Business Segments

The Company operates in four primary business segments: North America/Home Medical Equipment (North America/HME), Institutional Products Group (IPG), Europe and Asia/Pacific.

The North America/HME segment sells each of three primary product lines, which includes: lifestyle, mobility and seating and respiratory therapy products. IPG sells or rents long-term care medical equipment, health care furnishings and accessory products. Europe and Asia/Pacific sell product lines similar to North America/HME and IPG.

The Company evaluates performance and allocates resources based on profit or loss from operations before income taxes for each reportable segment. The accounting policies of each segment are the same as those described in the summary of significant accounting policies for the Company’s consolidated financial statements. Intersegment sales and transfers are based on the costs to manufacture plus a reasonable profit element. Therefore, intercompany profit or loss on intersegment sales and transfers is not considered in evaluating segment performance except for Asia/Pacific due to its significant intercompany sales volume relative to the segment.

The information by segment is as follows (in thousands): 
 
2014
 
2013
 
2012
Revenues from external customers
 
 
 
 
 
North America/HME
$
507,867

 
$
589,240

 
$
675,782

Institutional Products Group
102,796

 
112,290

 
126,508

Europe
610,555

 
583,143

 
546,543

Asia/Pacific
48,945

 
49,832

 
66,985

Consolidated
$
1,270,163

 
$
1,334,505

 
$
1,415,818

Intersegment revenues
 
 
 
 
 
North America/HME
$
84,247

 
$
77,553

 
$
104,291

Institutional Products Group
6,711

 
5,304

 
6,415

Europe
8,938

 
8,272

 
11,043

Asia/Pacific
26,173

 
24,941

 
32,587

Consolidated
$
126,069

 
$
116,070

 
$
154,336

Depreciation and amortization
 
 
 
 
 
North America/HME
$
10,925

 
$
12,149

 
$
11,681

Institutional Products Group
7,656

 
8,310

 
7,723

Europe
11,111

 
12,123

 
12,738

Asia/Pacific
2,406

 
3,073

 
4,505

All Other (1)
173

 
275

 
273

Discontinued Operations
518

 
859

 
1,673

Consolidated
$
32,789

 
$
36,789

 
$
38,593

Net interest expense (income)
 
 
 
 
 
North America/HME
$
348

 
$
(1,869
)
 
$
753

Institutional Products Group
2,244

 
3,656

 
4,288

Europe
(209
)
 
(53
)
 
(1,292
)
Asia/Pacific
149

 
960

 
3,304

Consolidated
$
2,532

 
$
2,694

 
$
7,053

Earnings (loss) before income taxes from continuing operations
 
 
 
 
 
North America/HME
$
(63,601
)
 
$
(50,506
)
 
$
(313
)
Institutional Products Group
(10,961
)
 
1,418

 
6,003

Europe
48,088

 
40,468

 
31,488

Asia/Pacific
(9,485
)
 
(13,258
)
 
(11,795
)
All Other (1)
(27,251
)
 
(21,581
)
 
(24,311
)
Consolidated
$
(63,210
)
 
$
(43,459
)
 
$
1,072

Assets
 
 
 
 
 
North America/HME (2)
$
218,877

 
$
250,239

 
$
280,383

Institutional Products Group (2)
60,080

 
84,229

 
118,190

Europe
638,896

 
693,790

 
683,751

Asia/Pacific (2)
30,231

 
31,034

 
39,605

All Other (1)
15,647

 
37,142

 
37,208

Assets held for sale
—

 
—

 
103,157

Consolidated
$
963,731

 
$
1,096,434

 
$
1,262,294

 
 
 
 
 
 
 
 
 
 
 
 
 
2014
 
2013
 
2012
Long-lived assets
 
 
 
 
 
North America/HME (2)
$
44,727

 
$
60,309

 
$
62,853

Institutional Products Group (2)
44,132

 
68,189

 
93,184

Europe
459,957

 
506,329

 
493,446

Asia/Pacific (2)
4,046

 
5,238

 
8,034

All Other (1)
15,527

 
36,830

 
36,828

Consolidated
$
568,389

 
$
676,895

 
$
694,345

Expenditures for assets
 
 
 
 
 
North America/HME
$
2,960

 
$
5,017

 
$
7,024

Institutional Products Group
1,232

 
3,308

 
5,234

Europe
6,708

 
4,809

 
4,604

Asia/Pacific
1,417

 
830

 
2,439

All Other (1)
—

 
50

 
—

Discontinued Operations
10

 
144

 
790

Consolidated
$
12,327

 
$
14,158

 
$
20,091

   ________________________
(1)
Consists of un-allocated corporate SG&A costs and intercompany profits, which do not meet the quantitative criteria for determining reportable segments. In addition, the “All Other” earnings (loss) before income taxes for 2012 includes loss on debt extinguishment including debt finance charges, interest and fees.

(2)
The 2014 IPG assets and long-lived assets include decreases of $13,041,000 due to intangible asset impairment write-offs. The 2013 IPG and North America/HME assets and long-lived assets include decreases of $1,356,000 and $167,000, respectively, due to intangible asset impairment write-offs. The 2012 IPG and North America/HME assets and long-lived assets decrease include a decrease of $677,000 and $96,000 related to intangible asset impairment write-offs in 2013.


Net sales by product, are as follows (in thousands):
 
2014
 
2013
 
2012
North America/HME
 
 
 
 
 
Lifestyle Products
$
239,625

 
$
267,934

 
$
288,144

Mobility and Seating
115,776

 
134,995

 
240,911

Respiratory Therapy
149,063

 
178,065

 
134,663

Other(1)
3,403

 
8,246

 
12,064


$
507,867

 
$
589,240

 
$
675,782

Institutional Products Group
 
 
 
 
 
Continuing Care
$
102,796

 
$
112,290

 
$
126,508

 
 
 
 
 
 
Europe
 
 
 
 
 
Lifestyle Products
$
322,370

 
$
303,225

 
$
285,707

Mobility and Seating
228,163

 
216,152

 
204,613

Respiratory Therapy
40,661

 
40,885

 
42,700

Other(1)
19,361

 
22,881

 
13,523


$
610,555

 
$
583,143

 
$
546,543

Asia/Pacific
 
 
 
 
 
Mobility and Seating
$
28,174

 
$
26,737

 
$
31,410

Lifestyle Products
11,772

 
12,023

 
15,448

Continuing Care
3,956

 
2,785

 
2,795

Respiratory Therapy
1,286

 
1,290

 
700

Other(1)
3,757

 
6,997

 
16,632

 
$
48,945

 
$
49,832

 
$
66,985

 
 
 
 
 
 
Total Consolidated
$
1,270,163

 
$
1,334,505

 
$
1,415,818

   ________________________
(1)
Includes various services, including repair services, equipment rentals and external contracting.
 
No single customer accounted for more than 2.9% of the Company’s sales.